Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1979 1
1980 1
1983 1
1987 1
1989 1
1993 1
1995 1
1998 2
2006 1
2012 2
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.
Jellinger KA. Jellinger KA. J Neural Transm (Vienna). 2019 Aug;126(8):933-995. doi: 10.1007/s00702-019-02028-6. Epub 2019 Jun 18. J Neural Transm (Vienna). 2019. PMID: 31214855 Review.
Recent genetic and molecular-biologic classifications distinguish (1) synucleinopathies (Parkinson's disease, dementia with Lewy bodies, Parkinson's disease-dementia, and multiple system atrophy); (2) tauopathies (progressive supranuclear palsy, corticobasal degeneration, FTLD-17 …
Recent genetic and molecular-biologic classifications distinguish (1) synucleinopathies (Parkinson's disease, dementia with Lewy bodies, Par …
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.
Jellinger KA. Jellinger KA. J Neural Transm (Vienna). 2019 Aug;126(8):997-1027. doi: 10.1007/s00702-019-02030-y. Epub 2019 Jun 24. J Neural Transm (Vienna). 2019. PMID: 31236685 Review.
Recent genetic and molecular classification distinguishes the following: (1) polyglutamine disorders (Huntington's disease and related disorders); (2) pantothenate kinase associated neurodegeneration; (3) Wilson's disease and related disorders; and (4) other hereditary neu …
Recent genetic and molecular classification distinguishes the following: (1) polyglutamine disorders (Huntington's disease and relate …
Alzheimer-type lesions in Huntington's disease.
Jellinger KA. Jellinger KA. J Neural Transm (Vienna). 1998;105(8-9):787-99. doi: 10.1007/s007020050095. J Neural Transm (Vienna). 1998. PMID: 9869319
Cognitive changes in Huntington's disease (HD) are variously related to diffuse cortical atrophy with neuron loss and dystrophic neurites leading to disruption of striato-frontal or limbic circuitries, while recent studies suggest an increasing prevalence of Alzheimer-like …
Cognitive changes in Huntington's disease (HD) are variously related to diffuse cortical atrophy with neuron loss and dystrophic neur …
Cerebral correlates of psychotic syndromes in neurodegenerative diseases.
Jellinger KA. Jellinger KA. J Cell Mol Med. 2012 May;16(5):995-1012. doi: 10.1111/j.1582-4934.2011.01311.x. J Cell Mol Med. 2012. PMID: 21418522 Free PMC article. Review.
It includes hallucinations, delusions including paranoia, aggressive behaviour, apathy and other psychotic phenomena that occur in a wide range of degenerative disorders including Alzheimer's disease, synucleinopathies (Parkinson's disease, dementia with Lewy bodies), Huntingt
It includes hallucinations, delusions including paranoia, aggressive behaviour, apathy and other psychotic phenomena that occur in a wide ra …
Interaction between pathogenic proteins in neurodegenerative disorders.
Jellinger KA. Jellinger KA. J Cell Mol Med. 2012 Jun;16(6):1166-83. doi: 10.1111/j.1582-4934.2011.01507.x. J Cell Mol Med. 2012. PMID: 22176890 Free PMC article. Review.
Novel findings that have shifted our understanding in the role of pathologic proteins in the pathogenesis of Alzheimer, Parkinson, Huntington and prion diseases, have confirmed correlations/overlaps between these and other neurodegenerative disorders. ...
Novel findings that have shifted our understanding in the role of pathologic proteins in the pathogenesis of Alzheimer, Parkinson, Huntin
Activated immune system in patients with Huntington's disease.
Leblhuber F, Walli J, Jellinger K, Tilz GP, Widner B, Laccone F, Fuchs D. Leblhuber F, et al. Clin Chem Lab Med. 1998 Oct;36(10):747-50. doi: 10.1515/CCLM.1998.132. Clin Chem Lab Med. 1998. PMID: 9853799
Abnormalities of immune system compartments were determined in 12 patients with Huntington's disease (eight males, four females; age 42.4+/-11.7 years) and 11 controls (7 males, 4 females; age 47.0+/-12.0). ...The data indicate an activation of various immune system compar …
Abnormalities of immune system compartments were determined in 12 patients with Huntington's disease (eight males, four females; age …
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Bernheimer H, et al. J Neurol Sci. 1973 Dec;20(4):415-55. doi: 10.1016/0022-510x(73)90175-5. J Neurol Sci. 1973. PMID: 4272516 No abstract available.
Clinicopathological analysis of dementia disorders in the elderly--an update.
Jellinger KA. Jellinger KA. J Alzheimers Dis. 2006;9(3 Suppl):61-70. doi: 10.3233/jad-2006-9s308. J Alzheimers Dis. 2006. PMID: 16914845
At autopsy, 86% revealed Alzheimer-related pathology, but only 42.8% showed "pure" Alzheimer disease, with additional cerebrovascular lesions in 22.6% and Lewy body pathology in 10.8%, while among 660 cases of clinically suspected Alzheimer disease, Alzheimer pathology was seen i …
At autopsy, 86% revealed Alzheimer-related pathology, but only 42.8% showed "pure" Alzheimer disease, with additional cerebrovascular lesion …
Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtellotte WW. Seeman P, et al. Neuropsychopharmacology. 1987 Dec;1(1):5-15. doi: 10.1016/0893-133x(87)90004-2. Neuropsychopharmacology. 1987. PMID: 2908095
Because dopamine D2 receptors are known to be elevated in schizophrenic brain striata, this study examined whether a similar dopamine receptor elevation occurred in other diseases including neuroleptic-treated Alzheimer's and Huntington's diseases. The average D1 density i …
Because dopamine D2 receptors are known to be elevated in schizophrenic brain striata, this study examined whether a similar dopamine recept …
Neurodegenerative disorders with extrapyramidal features--a neuropathological overview.
Jellinger KA. Jellinger KA. J Neural Transm Suppl. 1995;46:33-57. J Neural Transm Suppl. 1995. PMID: 8821040 Review.
In addition to progressive neuronal loss and gliosis involving specific subcortico-cortical systems or multiple circuits, many of these disorders are characterized by intracellular neuronal and/or glial inclusions indicating cytoskeletal dysmetabolism that may serve as important …
In addition to progressive neuronal loss and gliosis involving specific subcortico-cortical systems or multiple circuits, many of these diso …
15 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback